Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Autolus Therapeutics plc stock logo
AUTL
Autolus Therapeutics
$1.33
+3.1%
$1.46
$1.11
$5.00
$353.97M1.771.48 million shs2.83 million shs
Cryoport, Inc. stock logo
CYRX
Cryoport
$6.68
-0.7%
$5.95
$4.58
$13.68
$334.92M1.92543,066 shs475,735 shs
Medicus Pharma Ltd. stock logo
MDCX
Medicus Pharma
$6.73
+13.1%
$3.94
$1.80
$7.00
$90.38MN/A65,954 shs310,901 shs
SNDL Inc. stock logo
SNDL
SNDL
$1.35
+5.5%
$1.41
$1.24
$2.74
$354.75M3.682.11 million shs2.28 million shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Autolus Therapeutics plc stock logo
AUTL
Autolus Therapeutics
+5.74%-4.44%-7.86%-36.76%-67.18%
Cryoport, Inc. stock logo
CYRX
Cryoport
+4.02%-3.65%+19.75%0.00%-52.10%
Medicus Pharma Ltd. stock logo
MDCX
Medicus Pharma
-5.85%+42.34%+63.01%+61.68%+594,999,900.00%
SNDL Inc. stock logo
SNDL
SNDL
0.00%-1.92%-3.76%-31.18%-50.19%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Autolus Therapeutics plc stock logo
AUTL
Autolus Therapeutics
3.086 of 5 stars
3.53.00.00.02.73.30.6
Cryoport, Inc. stock logo
CYRX
Cryoport
2.8624 of 5 stars
4.41.00.00.02.22.50.6
Medicus Pharma Ltd. stock logo
MDCX
Medicus Pharma
N/AN/AN/AN/AN/AN/AN/AN/A
SNDL Inc. stock logo
SNDL
SNDL
3.1757 of 5 stars
3.53.00.00.03.00.01.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Autolus Therapeutics plc stock logo
AUTL
Autolus Therapeutics
3.00
Buy$9.32600.75% Upside
Cryoport, Inc. stock logo
CYRX
Cryoport
2.71
Moderate Buy$11.0064.67% Upside
Medicus Pharma Ltd. stock logo
MDCX
Medicus Pharma
3.50
Strong Buy$23.50249.18% Upside
SNDL Inc. stock logo
SNDL
SNDL
3.00
Buy$3.63168.52% Upside

Current Analyst Ratings Breakdown

Latest MDCX, SNDL, AUTL, and CYRX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/12/2025
Medicus Pharma Ltd. stock logo
MDCX
Medicus Pharma
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$14.00 ➝ $27.00
5/8/2025
Cryoport, Inc. stock logo
CYRX
Cryoport
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$11.00 ➝ $11.00
5/8/2025
Medicus Pharma Ltd. stock logo
MDCX
Medicus Pharma
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$10.00 ➝ $20.00
5/5/2025
Cryoport, Inc. stock logo
CYRX
Cryoport
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$8.00 ➝ $7.00
4/28/2025
Medicus Pharma Ltd. stock logo
MDCX
Medicus Pharma
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$14.00 ➝ $14.00
4/21/2025
Medicus Pharma Ltd. stock logo
MDCX
Medicus Pharma
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$14.00 ➝ $14.00
4/16/2025
Cryoport, Inc. stock logo
CYRX
Cryoport
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$11.00 ➝ $11.00
4/16/2025
Cryoport, Inc. stock logo
CYRX
Cryoport
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$10.00 ➝ $10.00
4/14/2025
Medicus Pharma Ltd. stock logo
MDCX
Medicus Pharma
D Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
4/14/2025
Medicus Pharma Ltd. stock logo
MDCX
Medicus Pharma
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$14.00
4/10/2025
Autolus Therapeutics plc stock logo
AUTL
Autolus Therapeutics
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$10.00 ➝ $10.00
(Data available from 5/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Autolus Therapeutics plc stock logo
AUTL
Autolus Therapeutics
$9.01M39.28N/AN/A$0.64 per share2.08
Cryoport, Inc. stock logo
CYRX
Cryoport
$214.83M1.56$0.39 per share16.95$9.45 per share0.71
Medicus Pharma Ltd. stock logo
MDCX
Medicus Pharma
N/AN/AN/AN/AN/AN/A
SNDL Inc. stock logo
SNDL
SNDL
$927.61M0.38N/AN/A$3.47 per share0.39
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Autolus Therapeutics plc stock logo
AUTL
Autolus Therapeutics
-$208.38M-$0.88N/AN/AN/AN/A-63.65%-36.54%N/A
Cryoport, Inc. stock logo
CYRX
Cryoport
-$99.59M-$2.34N/AN/AN/A-70.08%-13.35%-6.43%N/A
Medicus Pharma Ltd. stock logo
MDCX
Medicus Pharma
N/AN/A0.00N/AN/AN/AN/AN/A6/27/2025 (Estimated)
SNDL Inc. stock logo
SNDL
SNDL
-$127.91M-$0.29N/AN/AN/A-12.11%-8.27%-6.96%N/A

Latest MDCX, SNDL, AUTL, and CYRX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/12/2025Q1 2025
Medicus Pharma Ltd. stock logo
MDCX
Medicus Pharma
-$0.23-$0.42-$0.19-$0.42N/AN/A
5/8/2025Q1 2025
Autolus Therapeutics plc stock logo
AUTL
Autolus Therapeutics
-$0.24-$0.26-$0.02-$0.26$1.59 million$8.98 million
5/7/2025Q1 2025
Cryoport, Inc. stock logo
CYRX
Cryoport
-$0.23-$0.22+$0.01-$0.28$56.19 million$41.04 million
5/1/2025Q1 2025
SNDL Inc. stock logo
SNDL
SNDL
-$0.06-$0.04+$0.02-$0.04$214.60 million$142.38 million
3/28/2025Q4 2024
Medicus Pharma Ltd. stock logo
MDCX
Medicus Pharma
-$0.32-$0.18+$0.14-$0.18N/AN/A
3/20/2025Q4 2024
Autolus Therapeutics plc stock logo
AUTL
Autolus Therapeutics
-$0.21-$0.09+$0.12-$0.09$2.98 million$0.03 million
3/18/2025Q4 2024
SNDL Inc. stock logo
SNDL
SNDL
-$0.01-$0.19-$0.18-$0.19$248.10 million$179.06 million
3/4/2025Q4 2024
Cryoport, Inc. stock logo
CYRX
Cryoport
-$0.33-$0.42-$0.09-$0.42$58.71 million$59.53 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Autolus Therapeutics plc stock logo
AUTL
Autolus Therapeutics
N/AN/AN/AN/AN/A
Cryoport, Inc. stock logo
CYRX
Cryoport
N/AN/AN/AN/AN/A
Medicus Pharma Ltd. stock logo
MDCX
Medicus Pharma
N/AN/AN/AN/AN/A
SNDL Inc. stock logo
SNDL
SNDL
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Autolus Therapeutics plc stock logo
AUTL
Autolus Therapeutics
N/A
13.69
13.69
Cryoport, Inc. stock logo
CYRX
Cryoport
0.48
5.70
5.32
Medicus Pharma Ltd. stock logo
MDCX
Medicus Pharma
N/AN/AN/A
SNDL Inc. stock logo
SNDL
SNDL
0.10
5.61
4.16

Institutional Ownership

CompanyInstitutional Ownership
Autolus Therapeutics plc stock logo
AUTL
Autolus Therapeutics
72.83%
Cryoport, Inc. stock logo
CYRX
Cryoport
92.90%
Medicus Pharma Ltd. stock logo
MDCX
Medicus Pharma
N/A
SNDL Inc. stock logo
SNDL
SNDL
N/A

Insider Ownership

CompanyInsider Ownership
Autolus Therapeutics plc stock logo
AUTL
Autolus Therapeutics
25.70%
Cryoport, Inc. stock logo
CYRX
Cryoport
10.00%
Medicus Pharma Ltd. stock logo
MDCX
Medicus Pharma
N/A
SNDL Inc. stock logo
SNDL
SNDL
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Autolus Therapeutics plc stock logo
AUTL
Autolus Therapeutics
330266.14 million197.71 millionOptionable
Cryoport, Inc. stock logo
CYRX
Cryoport
1,02050.14 million44.44 millionOptionable
Medicus Pharma Ltd. stock logo
MDCX
Medicus Pharma
N/A13.43 millionN/AN/A
SNDL Inc. stock logo
SNDL
SNDL
580262.78 millionN/AOptionable

Recent News About These Companies

3 Marijuana Stocks For The Long Term Investing
These Cannabis Companies Are Repurchasing Shares
SNDL 1Q Loss Widens
SNDL Launches Rise Rewards Loyalty Program

New MarketBeat Followers Over Time

Media Sentiment Over Time

Autolus Therapeutics stock logo

Autolus Therapeutics NASDAQ:AUTL

$1.33 +0.04 (+3.10%)
Closing price 04:00 PM Eastern
Extended Trading
$1.33 0.00 (0.00%)
As of 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which is in a Phase 1 clinical trial in pediatric patients with relapsed or refractory ALL; AUTO4, a programmed T cell investigational therapy for the treatment of peripheral T-cell lymphoma targeting TRBC1 and TRBC2; AUTO6NG, a programmed T cell investigational therapy targeting GD2 in development for the treatment of neuroblastoma; and AUTO8, a product candidate to treat multiple myeloma. It focuses on developing AUTO5, a preclinical TRBC2 programmed T cell product candidate for the treatment of peripheral T-cell lymphoma. Autolus Therapeutics plc was incorporated in 2014 and is headquartered in London, the United Kingdom.

Cryoport stock logo

Cryoport NASDAQ:CYRX

$6.68 -0.05 (-0.74%)
Closing price 04:00 PM Eastern
Extended Trading
$6.67 -0.01 (-0.15%)
As of 04:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services. It also provides CRYOGENE, an unparalleled solution that offers pre-clinical temperature-controlled biological materials management services comprising specimen storage, processing, collection, and retrieval; CRYOPD, a temperature-controlled logistics solution, which include temperature-controlled packaging and transport solutions from cryogenic temperature to controlled ambient; and IntegriCell services that comprise apheresis/leukapheresis collection, Cryoshuttle transportation, cryo-process optimization and processing services. In addition, the company offers MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; MVE Biological Solutions' Vario cryogenic system, a cryogenic freezer system that supports temperatures between -20°C and -150°C; Cryoport Cryoshuttle provides clients with dedicated local transportation support; and Tec4Med. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; and incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.

Medicus Pharma stock logo

Medicus Pharma NASDAQ:MDCX

$6.73 +0.78 (+13.11%)
As of 04:00 PM Eastern

Medicus Pharma Ltd is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. Medicus Pharma Ltd is based in Toronto, Ontario.

SNDL stock logo

SNDL NASDAQ:SNDL

$1.35 +0.07 (+5.47%)
Closing price 04:00 PM Eastern
Extended Trading
$1.32 -0.03 (-1.85%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada. The company operates through Liquor Retail, Cannabis Retail, Cannabis Operations, and Investments segments. It engages in the cultivation, distribution, and sale of cannabis for the adult-use and medical markets; sells wines, beers, and spirits through wholly owned liquor stores; and private sale of recreational cannabis through wholly owned and franchised retail cannabis stores. In addition, the company produces and distributes inhalable products, such as flower, pre-rolls, and vapes. It offers its products under the Top Leaf, Sundial Cannabis, Palmetto, and Grasslands brands. The company was formerly known as Sundial Growers Inc. and changed its name to SNDL Inc. in July 2022. SNDL Inc. was incorporated in 2006 and is headquartered in Calgary, Canada.